Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.

Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel

Journal article

Adams ER. et al, (2020), Wellcome Open Research, 5, 139 - 139

An evidence-based framework for priority clinical research questions for COVID-19.

Journal article

Harris C. et al, (2020), Journal of global health, 10

A novel scoring system for prediction of disease severity in COVID-19

Journal article

DONG TAO., (2020), Frontiers in Cellular and Infection Microbiology, section Virus and Host

Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review.

Journal article

Dagens A. et al, (2020), BMJ (Clinical research ed.), 369

Human cancer germline antigen-specific cytotoxic T cell-what can we learn from patient.

Journal article

Abd Hamid M. et al, (2020), Cellular & molecular immunology

Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?

Journal article

Cheung VTF. et al, (2020), British Journal of Cancer

Inflammatory Bowel Disease Through the Lens of Single-cell RNA-seq Technologies.

Journal article

Corridoni D. et al, (2020), Inflammatory bowel diseases

Lassa fever in pregnancy: a systematic review and meta-analysis

Journal article

Kayem ND. et al, (2020), Transactions of The Royal Society of Tropical Medicine and Hygiene, 114, 385 - 396

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.

Journal article

Cao B. et al, (2020), The New England journal of medicine, 382, 1787 - 1799

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.

Journal article

Wang Y. et al, (2020), Lancet (London, England), 395, 1569 - 1578

Load More